Organ transplantation offers great promise for children with end-stage lung disease. The Children's Hospital of Philadelphia's Lung Transplant Program is one of the largest in the world and draws upon the collaboration of a closely-knit multi-disciplinary healthcare team.
Under the leadership of Thomas Spray, MD, Surgical Director of Thoracic Organ Transplant, and Samuel Goldfarb, MD, Medical Director, Lung Transplantation, our program is known both for its excellence and for its comprehensive approach to care. We have performed more than 67 lung transplants and more than 25 heart-lung transplants. Our outcomes are among the best in the world.
If your child is referred to us, we will evaluate him or her and meet with your family before your child is placed on the transplant list. Our goal is first to investigate other treatment options that could improve your child's health and quality of life. We explore medical therapies and other types of surgeries that may eliminate the need for transplantation.
We consider lung transplantation if a child has end-stage pulmonary (lung) disease, his or her life expectancy is limited and no other treatment options are available.
Lung transplants can now be performed in all ages — from newborn to adult. A child may need a transplant if he or she has certain conditions, including:
Whether your child would benefit from lung transplantation is a complex issue that must be carefully and individually evaluated.
If you are considering a lung or heart/lung transplant evaluation, please request an evaluation with the Lung Transplant Program at The Children's Hospital of Philadelphia as early as possible. Please call our Transplant Administrator at 267-426-0664 or send the Lung Transplant team an e-mail.
If you are a physician or a nurse practitioner and would like to refer a patient, please call 215-590-0388 or send an email to Samuel Goldfarb, the Medical Director of Lung and Heart/Lung Transplant Programs.